Drug Search Results
More Filters [+]

Incyclinide

Alternative Names: incyclinide
Latest Update: 2023-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: MMP Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Incyclinide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Sarcoma, Kaposi|HIV Infections|Brain Stem Cancer

Phase 1: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCI-2012-02924

P2

Terminated

HIV Infections|Sarcoma, Kaposi

2005-11-01

CDR0000066830

P1

Completed

Oncology Solid Tumor Unspecified

2002-04-01

CDR0000067379

P2

Completed

Brain Stem Cancer

None

Recent News Events